Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Dermatologic 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia 7Lymphoma 3Sezary Syndrome 2Mycosis Fungoides 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Large Granular Lymphocytic 2Waldenstrom Macroglobulinemia 1Recurrence 1Neoplasms 1Mucositis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Prolymphocytic, T-Cell 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1

Interventions

Peripheral Blood Stem Cell Transplantation 28fludarabine phosphate 25Cyclophosphamide 19Cyclosporine 18Whole-Body Irradiation 17Mycophenolic Acid 17Tacrolimus 15Busulfan 13Antilymphocyte Serum 11Methotrexate 10Methylprednisolone 8Filgrastim 8Vorinostat 7Radiotherapy 7Flow Cytometry 7Etoposide 7Bortezomib 6Psychiatric Rehabilitation 5Everolimus 5Dexamethasone 5Bexarotene 5Alemtuzumab 5Transplantation 4Therapeutics 4Polymerase Chain Reaction 4Panobinostat 4Lenalidomide 4Gemcitabine 4Carboplatin 4Calcium Dobesilate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Sezary Syndrome × nelarabine × Clear all
NCT01094860 2020-02-11

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
29 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Recurrence, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Leukemia, Prolymphocytic, B-Cell

NCT00005080 2013-01-16

506U78 in Treating Patients With Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
74 enrolled
DermatologicLymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡